2013/2903(DEA) | [ParlTrack]

Changes: 2021/05/04events.type, events.docs.url, docs.docs.url, 2019/08/07committees.date, 2019/07/06events, procedure.dossier_of_the_committee, activities, committees, procedure.subject, docs, links, other, procedure.summary, 2015/11/10procedure.subject, 2015/05/27procedure.subject, 2014/07/27activities.body, 2014/01/18activities.type, 2014/01/16activities, procedure.stage_reached, 2014/01/08activities, procedure.stage_reached, 2013/10/26activities, procedure.dossier_of_the_committee, procedure.stage_reached

View current state | View Changes for this date

General Activities Documents History

2013/2903(DEA) Exemption for lead acetate markers for use in stereotactic head frames for use with CT (Computed Tomography) and MRI and in positioning systems for gamma beam and particle therapy equipment

Role	Committee	Rapporteur	Shadows
Lead	ENVI

Subjects

Links

Activites

2013/10/18 Initial period for examining delegated act 2 month(s)
2013/10/18 Non-legislative basic document
- C(2013)06794

Documents

Non-legislative basic document published: C(2013)06794

History

(these mark the time of scraping, not the official date of the change)

2013-10-26Show (3) Changes | Timetravel

activities/2	date 2013-10-23T00:00:00 body EP type Committee referral announced in Parliament, 1st reading/single reading committees body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
procedure/dossier_of_the_committee	ENVI/7/14362
procedure/stage_reached	Old Preparatory phase in Parliament New Awaiting committee decision

2013-10-24Show (5) Changes

activities	date: 2013-10-18T00:00:00 body: unknown type: Initial period for examining delegated act 2 month(s) date: 2013-10-18T00:00:00 docs: type: Non-legislative basic document published title: C(2013)06794 type: Non-legislative basic document body: EC commission:
committees	body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
links
other
procedure	reference 2013/2903(DEA) title Exemption for lead acetate markers for use in stereotactic head frames for use with CT (Computed Tomography) and MRI and in positioning systems for gamma beam and particle therapy equipment stage_reached Preparatory phase in Parliament summary Supplementing subtype Examination of delegated act type DEA - Delegated acts procedure subject 3.40.06 Electronics, electrotechnical industries 3.70.13 Dangerous substances, toxic and radioactive wastes (storage, transport)

Activites

Documents

History

ParlTrack - 2011-2024